Boland et al
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously a mechanism that sets it apart from existing licensed treatments
While appearing on TODAY last year, the mother-of-four said the experience 'taught me a lot about my lifestyle and my health' and that she 'more energy than ever.' She revealed to hosts Hoda Kotb and Savannah Guthrie that she completely cut out sugar, junk food and fried foods from her diet
Having support systems in place, whether friends, family, online communities, or healthcare providers, makes a meaningful difference in treatment persistence
Its gaining recognition for its effectiveness in promoting significant weight reduction when combined with a well-designed, supervised weight management plan
Patients should consult with their healthcare provider before starting this medication.